Stay updated on CT-P27 Efficacy and Safety in Influenza Challenge Clinical Trial
Sign up to get notified when there's something new on the CT-P27 Efficacy and Safety in Influenza Challenge Clinical Trial page.

Latest updates to the CT-P27 Efficacy and Safety in Influenza Challenge Clinical Trial page
- Check4 days agoChange DetectedThe record presents details of Celltrion’s completed Phase 2 study evaluating CT-P27 against placebo in an influenza challenge model, including participant criteria, treatment arms, outcomes, and study dates.SummaryDifference35%

- Check11 days agoChange DetectedThe footer now identifies the site revision as v3.8.0 instead of v3.7.2; the page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH-wide notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page displays a 403 Forbidden error with a minimal header (Home link visible), indicating access is blocked. Previously visible study record details and related sections appear to be removed from the page.SummaryDifference15%

- Check60 days agoChange DetectedThe page shows a new revision badge, updating from v3.6.6 to v3.7.0, indicating a software/maintenance update. The study details and user-facing content remain unchanged.SummaryDifference0.1%

Stay in the know with updates to CT-P27 Efficacy and Safety in Influenza Challenge Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P27 Efficacy and Safety in Influenza Challenge Clinical Trial page.